Updated: Oct 29, 2021
Congratulations to our colleagues at Erasmus University Medical Center in Rotterdam, who have recently published their work on the prophylactic use of Scopolamine Butylbromide for preventing end of life death rattle in the Journal of the American Medical Association (JAMA).
The article prompted a high level of interest and was the subject of both a JAMA editorial and a podcast from the AMA Education Hub. You can find links to these resources below:
This groundbreaking study has the potential to change practice in end of life care around the world.